Extension capital now powers the majority of VC funding, with OrbiMed’s $3 B raise highlighting the shift to later‑stage, sector‑focused investments. Posted on October 16, 2026 by admin@ebotweb.com This post is available to ebotweb.com subscribers. Log in or subscribe to continue reading.